 | Outlook Therapeutics, Inc. (NASDAQ:OTLK) Director Acquires $13,900.00 in Stock
americanbankingnews.com - December 2 at 8:56 PM |
| Outlook Therapeutics, Inc. (NASDAQ:OTLK) Director Acquires $20,000,000.00 in Stock
americanbankingnews.com - December 1 at 8:18 PM |
 | Outlook Therapeutics Announces Closing of $57.5 Million Bought Deal, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
finance.yahoo.com - November 29 at 8:11 PM |
 | Thinking about buying stock in Naked Brand, Biolase, Gap, Inspira Technologies, or Outlook Therapeutics?
benzinga.com - November 24 at 5:48 PM |
| What Type Of Shareholders Make Up Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) Share Registry?
finance.yahoo.com - November 24 at 12:48 PM |
| Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $50 Million
finance.yahoo.com - November 24 at 2:46 AM |
| Outlook Therapeutics Announces $10 Million Bought Deal Offering of Common Stock
finance.yahoo.com - November 23 at 4:46 PM |
| Reviewing Bio-Techne (NASDAQ:TECH) and Outlook Therapeutics (NASDAQ:OTLK)
americanbankingnews.com - November 23 at 1:10 AM |
| Outlook Therapeutics to Present at the Virtual Investor Roundtable Event
finance.yahoo.com - November 10 at 9:54 AM |
| Outlook Therapeutics to Present at the [email protected] 2021 Conference Retina Showcases
finance.yahoo.com - November 3 at 12:52 PM |
|
| Outlook Therapeutics’ Positive NORSE THREE Safety Data Presented at 2021 American Society of Retina Specialists for ONS-5010 Ophthalmic Bevacizumab
finance.yahoo.com - October 12 at 3:16 PM |
 | Outlook Therapeutics, Inc. (NASDAQ:OTLK) stock was sold by a number of insiders in the recent year, which isn't a positive indicator for investors
nasdaq.com - October 11 at 6:31 PM |
| Outlook Therapeutics to Present at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
finance.yahoo.com - October 7 at 12:33 PM |
 | Outlook Therapeutics Reports Positive 12-Month Safety Data From Phase 3 Trial On Wet AMD
markets.businessinsider.com - September 28 at 10:01 AM |
| Outlook Therapeutics Reports New Positive 12-Month Safety Data from Pivotal Phase 3 NORSE TWO Trial
finance.yahoo.com - September 28 at 10:01 AM |
| Outlook Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
finance.yahoo.com - September 21 at 8:28 AM |
| Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference
finance.yahoo.com - September 13 at 8:53 AM |
| Outlook Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 8 at 5:45 PM |
 | Weekly Stock Market Outlook 30 August to 5 September 2021: Know What May Happen in Stock Market This Week | Profit Margins to Investing Decisions
msn.com - August 30 at 7:17 AM |
| Stable Outlook! Ind-Ra upgrades Yes Bank’s long-term issuer rating to ‘IND BBB’ - SIGNIFICANT IMPROVEMENT!
msn.com - August 27 at 4:29 PM |
| Is Outlook Therapeutics (NASDAQ:OTLK) Weighed On By Its Debt Load?
nasdaq.com - August 26 at 4:04 PM |
| Outlook Therapeutics (NASDAQ:OTLK) shareholder returns have been splendid, earning 198% in 1 year
finance.yahoo.com - August 26 at 4:04 PM |
| Outlook Therapeutics Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
finance.yahoo.com - August 13 at 11:11 AM |
| Outlook Therapeutics to Participate at the H.C. Wainwright Ophthalmology Virtual Conference
finance.yahoo.com - August 11 at 9:48 AM |
| Outlook Therapeutics to Participate at the H.C. Wainwright Ophthalmology Virtual Conference
finance.yahoo.com - August 11 at 9:48 AM |
| Why Outlook Therapeutics Stock Surged Today
finance.yahoo.com - August 3 at 5:57 PM |
| OTLK Stock: The Huge Trial News Lifting Outlook Therapeutics
msn.com - August 3 at 12:57 PM |
| Outlook Therapeutics Stock Soars on Positive Results for Eye Treatment
finance.yahoo.com - August 3 at 12:57 PM |
| Outlook Therapeutics Stock Surges Positive ONS-5010 Data In Wet AMD Patients
markets.businessinsider.com - August 3 at 7:57 AM |
| Outlook Therapeutics Reports Positive Efficacy and Safety Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
finance.yahoo.com - August 3 at 7:57 AM |
| Outlook on the Flame Retardant Chemicals Global Market to 2029 - Regulations for Fire Safety are Becoming More Stringent Driving Growth
benzinga.com - July 15 at 11:42 AM |
 | Outlook Therapeutics Names Trenary as President, CEO >OTLK
marketwatch.com - July 7 at 2:11 PM |
|
| Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer
finance.yahoo.com - July 7 at 9:10 AM |
| Does Outlook Therapeutics (NASDAQ:OTLK) Have A Healthy Balance Sheet?
finance.yahoo.com - July 2 at 1:54 PM |
| Outlook Therapeutics Announces Inclusion in the Russell 2000® Index
finance.yahoo.com - June 14 at 12:49 PM |
 | OUTLOOK THERAPEUTICS INC(OTLK)
fool.com - June 10 at 12:34 AM |
| BRIEF-Outlook Therapeutics Reports Completion Of Patient Dosing In The Ons-5010 Pivotal Phase 3 Norse Two Trial
msn.com - June 8 at 1:32 PM |
| Outlook Therapeutics Reports Completion of Patient Dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial
finance.yahoo.com - June 8 at 8:31 AM |
| Outlook Therapeutics (NASDAQ:OTLK) Shareholders Have Enjoyed An Impressive 118% Share Price Gain
nasdaq.com - June 7 at 2:18 PM |
| Current Therapies and Emerging Drugs in the Prediabetes Pipeline Soon to Boost the Treatment Outlook
sg.finance.yahoo.com - June 2 at 8:11 PM |
| Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010
finance.yahoo.com - May 27 at 12:36 PM |
| How Many Outlook Therapeutics, Inc. (NASDAQ:OTLK) Shares Do Institutions Own?
finance.yahoo.com - May 18 at 1:19 PM |
| 'Earth angels' at New Outlook Center help with cancer navigation
msn.com - May 17 at 2:19 PM |
| Outlook Therapeutics Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Corporate Update
finance.yahoo.com - May 14 at 9:47 AM |
| Outlook Therapeutics to Host Virtual Clinical Day on May 20, 2021
finance.yahoo.com - May 12 at 10:09 AM |
 | Outlook Therapeutics is bringing a treatment for retinal disease to the market at the right time
proactiveinvestors.com - April 29 at 2:22 PM |
 | Outlook Therapeutics Stock Gives Every Indication Of Being Significantly Overvalued
uk.finance.yahoo.com - April 23 at 1:31 AM |
 | iOS Microsoft Outlook app updates with a change to device notifications
onmsft.com - April 13 at 8:38 AM |
| Outlook Therapeutics 'almost complete' with pivotal Phase 3 NORSE TWO trial to treat wet AMD
proactiveinvestors.com - April 12 at 7:09 PM |
| Outlook Therapeutics Reports Positive Safety Profile from NORSE THREE Open-Label Safety Study for ONS-5010 / LYTENAVA™ (bevacizumab-vikg)
finance.yahoo.com - March 31 at 12:50 PM |
